References
- Segerson TP, Kauer J, Wolfe HC, Mobtaker H, Wu P, Jackson IM, Lechan RM. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 1987;238:78–80.
- Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Rev 2002;23:38–89.
- Kakuscka I, Rand W, Lechan RM. Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology 1992;130: 2845–50.
- Chopra IJ, Solomon DH, Chua Teco GN Thyroxine: just a prohormone or a hormone too? JCEM 1973;36:1050–7.
- Crantz FR, Silva JE, Larsen PR. An analysis of the sourses and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear recptors in rat cerebral cortex and cerebellum. Endocrinology 1982;110:367–75.
- Sjöberg S, Eriksson M, Nordin C. L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol 1998; 139:493–7.
- Gunnarsson T, Sjöberg S, Eriksson M, Nordin C. Cholecystokinin peptides in cerebrospinal fluid: a pilot study in hypothyroid patients. Hum Psychopharmacol 1999;14:113–7.
- Hagen GA, Solberg LA Jr. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 1974;95:1398–10.
- Bertilsson L, Åsberg M. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects. Usdin E, Åsberg M, Bertilsson L, Sjöqvist F. Frontiers in biochemical and pharmacological research in depression. New York: Raven Press; 1984, 27–34.
- Burman P, Hetta J, Wide L, Månsson J-E, Ekman R, Karlsson FA. Growth hormone treatment affects brain neurotransmittors and throxine. Clinical Endocrinology. 1996;44:319–24.
- Kirkegard C, Faber J. Free thyroxine and 3,3′,5′-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol 1991;124:166–72.
- Malin J-P, Ködding R, Fuhrmann H, von zur Mühlen A. T4, T3 and r T3 levels in serum and cerebrospinal fluid of patients with amylotrophic lateral sclerosis. J Neurol 1989;236:57–9.
- Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. Identifcation of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003;278:40128–35.
- Heuer J, Maier MK, Iden S. Mittag J, Friesema EC, Visser TJ, Bauer K. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 2005;146:1701–6.
- Jansen J, Friesema EC, Milici C, Visser TJ. Thyroid hormone transporters in health and disease. Thyroid 2005;15:757–68.
- Bernal J. The significance of thyroid hormone transporters in the brain. Endocrinology 2005;146:1698–00.
- Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocrinol Rev 1981;2: 87–102.
- Köhrle J, Schomburg L, Drescher S, Fekete E, Bauer K. Rapid stimulation of type I 5´-deoidinase in rat pituitaries by 3, 3´,5-triiodo-L-thyronine. Mol Cell Endocrinol 1995; 108:17–21.
- Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 1970;49: 855–64.
- Surks MI, Schadlow AR, Stock JM, Oppenheimer JH. Determination of iodothyronine absorption and conversion of L-thyroxine (T4) to L-triiodothyronine (T3) using turnover rate techniques. J Clin Invest 1973;52:805–11.